Showing results (261-270 of 4,869) with videos related to

Sort By:
Pageof 487
Urologic Oncology|March 29, 2017
Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinomaJung Kwon Kim, Kyung Chul Moon, Chang Wook Jeong, et al.
Urologic Oncology|April 2, 2017
End-stage renal disease secondary to renal malignancy: Epidemiologic trends and survival outcomesKevin A Nguyen, Srinivas Vourganti, Jamil S Syed, et al.
Urologic Oncology|March 7, 2021
Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensusWei Phin Tan, Ardeshir R Rastinehad, Laurence Klotz, et al.
Urologic Oncology|February 17, 2019
Robotic vs. open cystectomy: How length-of-stay differences relate conditionally to ageKassem Faraj, Yu-Hui H Chang, Matthew R Neville, et al.
Urologic Oncology|February 17, 2019
Population-based outcomes of men with a single negative prostate biopsy: Importance of continued follow-up among older patientsRashid K Sayyid, Shabbir M H Alibhai, Rinku Sutradhar, et al.
Urologic Oncology|August 4, 2019
Systematic prostate biopsy still matters: A comprehensive analysis of MRI/TRUS-fusion targeted prostate biopsies across different indicationsNiklas Westhoff, Bettina Baeßler, Jost von Hardenberg, et al.
Urologic Oncology|August 18, 2019
Propensity-matched analysis of stage-specific efficacy of adjuvant chemotherapy for bladder cancerFelix V Chen, Tulay Koru-Sengul, Feng Miao, et al.
Urologic Oncology|October 1, 2022
Impact of COVID-19 on Society of Urologic Oncology fellowship operative volumesAdam M Daily, Hannah G Koenig, Eyal Kord, et al.
Urologic Oncology|September 27, 2022
A decade of declining prostatectomy margin positivity within a prostate cancer clinical quality registryNathan Papa, Marlon Perera, Jonathan G Bensley, et al.
Urologic Oncology|February 15, 2021
Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancerGregory T Chesnut, Amy L Tin, Arjun Sivaraman, et al.
Pageof 487